Maternal MitoQ Treatment Is Protective Against Programmed Alterations in CYP Activity Due to Antenatal Dexamethasone

Maternal MitoQ Treatment Is Protective Against Programmed Alterations in CYP Activity Due to Antenatal Dexamethasone

<b>Background/Objectives</b>: In pregnancy threatened by preterm birth, antenatal corticosteroids (ACS) are administered to accelerate fetal lung maturation. However, they have side effects, including the production of reactive oxygen species that can impact cytochrome P450 (CYP) activit...

Full description

Saved in:
Bibliographic Details
Main Authors: Millicent G. A. Bennett, Ashley S. Meakin, Kimberley J. Botting-Lawford, Youguo Niu, Sage G. Ford, Michael P. Murphy, Michael D. Wiese, Dino A. Giussani, Janna L. Morrison
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Pharmaceutics
Subjects:
antioxidant
antenatal corticosteroids
pregnancy
cytochrome p450
liver
offspring
Online Access:https://www.mdpi.com/1999-4923/17/3/285
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items